These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3352557)

  • 1. [Ganglioside therapy in uremic polyneuropathy].
    Krämer G; Süss W; Köhler H; Schneider B; Hopf HC
    Med Klin (Munich); 1988 Jan; 83(1):7-11, 40. PubMed ID: 3352557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic polyneuritis. Significance of determination of neural conduction velocity (NCV) and level of mean molecules (MM)].
    El Matri A; Ben Dridi M; Belkahia C; Ben Abdallah T; Crevat A; Ben Maiz H; Ben Ayed H
    Tunis Med; 1979; 57(6):348-51. PubMed ID: 555111
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment of chronic chagasic cardioneuropathy with a mixture of gangliosides: effect on evolution of circulating antiGM1 antibodies.
    Mitelman J; Gimenez L; Aparicio NJ; Cortelezzi M
    J Cardiol; 1999 Oct; 34(4):189-97. PubMed ID: 10553535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gangliosides in the postoperative period in disk hernia].
    de Blas Orlando A; Martinez Cubells J; Hernando Arrivas C; del Pozo Garcia JM
    Rev Clin Esp; 1983 Feb; 168(3):193-8. PubMed ID: 6346409
    [No Abstract]   [Full Text] [Related]  

  • 5. F-waves in evaluating uremic polyneuropathy: a long-term study after the application of continuous ambulatory peritoneal dialysis.
    Peioglou-Harmoussi S; Dimitriadis A; Antoniou S; Noitsi-Michali F; Logothetis J
    Funct Neurol; 1987; 2(2):195-205. PubMed ID: 3666549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular complications in uremics: a review.
    Al-Hayk K; Bertorini TE
    Neurologist; 2007 Jul; 13(4):188-96. PubMed ID: 17622910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
    Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
    Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of renal transplantation on uremic polyneuropathy].
    Valli G; Schönhuber R; Freschi R
    Riv Neurol; 1974; 44(3):196-204. PubMed ID: 4610689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Uremic neuropathy. Clinical and neurophysiological data on patients on chronic hemodialysis treatment].
    Ministeri CM; Mucaria A; Bennici S; Visconti G; Calabrese S; De Gregorio A
    Clin Ter; 1986 Jul; 118(2):89-92. PubMed ID: 3742981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies on the use of gangliosides in acute cerebrovascular diseases].
    Lipparini R; Broccoli PL; Albini U; Pangia A
    Minerva Med; 1975 Oct; 66(72):3774-84. PubMed ID: 1103014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early uremic polyneuropathy. Electromyographic study].
    Mariani G; Cosi V
    Riv Neurol; 1971; 41(2):126-32. PubMed ID: 4331237
    [No Abstract]   [Full Text] [Related]  

  • 12. [Uremic polyneuropathy. Case studies].
    Fierro B; Fradà G; Li Vecchi M; Raimondo D
    Arch Sci Med (Torino); 1981; 138(4):609-14. PubMed ID: 7340740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Uremic neuropathy: clinical evolution and therapeutic results in a 5-year period of observation].
    Bernardi A; Biasia F; Scapin P; Bucciante G; Dainese R; Brazzo F; Hanau R
    G Clin Med; 1982 Jan; 63(1):29-36. PubMed ID: 7049810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uremic polyneuropathy in patients treated by chronic hemodialysis].
    Il'ina NA; Ermolenko VM; Ostroumova IV; Ivanchenko OV; Potomskaia LZ
    Sov Med; 1974 Nov; (11):93-8. PubMed ID: 4373841
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gangliosides: a new prospective therapy of uremic neuropathy].
    Bernardi A; Dainese R; Brazzo F; Caniato G; Uliari U; De Stefani D; Poluzzi P; Bernardi G
    Clin Ter; 1983 Feb; 104(3):211-8. PubMed ID: 6861458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Uremic polyneuropathy].
    el Aklouk I; Basić Kes V; Basić-Jukić N; Brunetta B; Kes P
    Acta Med Croatica; 2004; 58(1):59-61. PubMed ID: 15125395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sympathetic block series. A component of the pain therapy concept in polyneuropathies].
    Hankemeier U; Krizanits F
    Fortschr Med; 1987 Apr; 105(13):255-7. PubMed ID: 3596443
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
    Bae JS; Kim BJ
    J Clin Neurosci; 2005 Sep; 12(7):808-10. PubMed ID: 16054817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early uremic polyneuropathy: clinical and electromyographic study of subjects with and without treatment with extracorporeal dialysis].
    Mariani G; Cosi V; Faggi L; Zelaschi F
    Riv Neurobiol; 1971; 17(1):67-95. PubMed ID: 4333105
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.